Loading... Please wait...

Our Newsletter


STI571 (Imatinib, Gleevec) | Abl/cKit/PDGFR inhibitor

  • STI571 (Imatinib, Gleevec).jpg
  • STI571 (Imatinib, Gleevec), 400x400px, png
Price:
$59.00
Catalog #:
C6784-10
Quantity:


Product Description

Imatinib is an orally-available, aminopyrimidine-based inhibitor of Abl, c-Kit, and PDGFR with cellular phosphorylation inhibition IC50 value of 0.1 uM. [1]

Focused studies on c-Kit show that Imatinib inhibits activity of both wild-type and mutant c-Kit, as well as c-Kit-dependent activation of Akt. [2] Furthermore, Imatinib completely suppresses activation of MAPK and the antiapoptotic effect of c-Kit activation.

Studies on the PDGF receptors show that Imatinib preferentially inhibits the both a and b isoforms, but not the closely related c-Fms, Flt3, KDR, Flt1, and TEK tyrosine kinases. [3] In addition, Imatinib inhibits stem cell factor-mediated cellular signalling, including ligand-stimulated receptor autophosphorylation and inositol phosphate formation.


Technical information:

Chemical Formula:   C29H31N7O.CH4SO3
CAS #:   220127-57-1
Molecular Weight:   589.4
Purity:   >99%
Appearance:   White
Chemical Name:   4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide Methanesulfonate
Solubility:   Up to 22 mM in DMSO
Synonyms:   STI-571, STI 571, STI571, Imatinib mesylate, Gleevec, Glivec

Shipping Condition: The product is shipped in a glass vial at ambient temperature.
Storage condition: For longer shelf life, store solid powder at 4oC desiccated, or store DMSO solution at -20oC.


Reference:

1. Capdeville et al., Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug. Nat. Rev. Drug. Disc. 2002, 1, 493-502. Pubmed ID: 12120256
2. Heinrich et al., Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor. Blood, 2000, 96(3), 925-932. Pubmed ID: 10910906
3. Buchdunger et al., Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J. Pharmacol. Exp. Ther. 2000, 295(1), 139-145. Pubmed ID: 10991971

Other Information:

Product Specification (pdf)
MSDS (pdf)
Certificate of Analysis is available upon request.

Write your own product review

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product!

Add to Wish List

Click the button below to add the STI571 (Imatinib, Gleevec) | Abl/cKit/PDGFR inhibitor to your wish list.

You Recently Viewed...